Month: February 2021

Immunicum AB (publ) Announces Year-End Results 2020

Written by Customer Service on February 18, 2021. Posted in Earnings Releases And Operating Results.

Press Release18 February 2021Immunicum AB (publ) Announces Year-End Results 2020OCTOBER-DECEMBER IN SUMMARYNet sales for the period amounted to KSEK – (-)*.Result for the period amounted to KSEK -47,568 (19,409)*.Earnings and diluted earnings per share totaled SEK -0.57 (-0.26)*.Immunicum announced the last safety and enrollment update for the ongoing Phase Ib/II ILIAD combination trial. As of October 6, 15 patients were enrolled in the study and ilixadencel maintained a favorable safety profile. The Dose Escalation Committee confirmed there were no dose limiting toxicities. Immunicum received Orphan Drug Designation from the US Food and Drug Administration (FDA) for ilixadencel in Hepatocellular Carcinoma (HCC).Board member Magnus Persson left the Board in October.On November 18, Immunicum announced that the Company had entered into...

Immunicum AB (publ) publicerar bokslutskommuniké 2020

Written by Customer Service on February 18, 2021. Posted in Earnings Releases And Operating Results.

Pressmeddelande18 februari 2021Immunicum AB (publ) publicerar bokslutskommuniké 2020OKTOBER – DECEMER I SAMMANDRAGNettoomsättning för kvartalet uppgick till – (-)*.Periodens resultat uppgick till KSEK -47 568 (-19 409)*.Resultat per aktie före och efter utspädning uppgick till SEK -0,57 (-0,26)*.Immunicum tillkännagav en säkerhets- och inklusionsuppdatering för den pågående Fas I/II-kombinationsstudien ILIAD. Per den 6 oktober hade totalt 15 patienter inkluderats i prövningen och ilixadencel har uppvisat en konsekvent säkerhetsprofil i studien. Doseskaleringskommittén bekräftade att det inte förekommit några dosbegränsande toxiciteter.Styrelseledamoten Magnus Persson lämnade styrelsen i oktober.Den 18 november offentliggjorde Immunicum att bolaget ingått ett bindande avtal med Van Herk Investments BV om att förvärva samtliga...

Innofactor Oyj:n tilinpäätöstiedote 2020 (IFRS)

Written by Customer Service on February 18, 2021. Posted in Earnings Releases And Operating Results.

Innofactor Oyj:n tilinpäätöstiedote 18.2.2021 klo 9.00 Innofactor saavutti vuonna 2020 koronasta ja yksittäisestä vuodelta 2019 tehdystä projektin alaskirjauksesta huolimatta historiansa parhaan liikevaihdon, käyttökatteen ja tilauskannan

Anaqua acquiert Quantify IP pour offrir à ses clients des capacités de budgétisation et de prévision des coûts de propriété intellectuelle avancées

Written by Customer Service on February 18, 2021. Posted in Mergers And Acquisitions.

BOSTON, 18 févr. 2021 (GLOBE NEWSWIRE) — Anaqua, leader dans le domaine des solutions de gestion PI, a annoncé aujourd’hui l’acquisition de Quantify IP, fournisseur global de logiciel d’estimation de coûts PI. Cette transaction vient renforcer l’offre de solutions de gestion PI d’Anaqua et apporte aux entreprises et aux Conseils de nouvelles fonctionnalités de prévisions et de budgétisation de coûts visant à améliorer leur stratégie PI.Anaqua va continuer à investir dans les produits phares de Quantify IP, Global IP Estimator® et Portfolio Estimator et les proposer de manière indépendante ou intégrés au sein de son logiciel de gestion PI. Global IP Estimator aide les professionnels de la PI à générer des estimations de coûts liés aux demandes de dépôts de marques, brevets, dessins et modèles. Portfolio Estimator aide les professionnels...

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

Written by Customer Service on February 18, 2021. Posted in Public Companies.

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.To participate, please dial one of the following numbers and reference conference ID 7681320:+1-888-317-6003 for callers in the United States+1-412-317-6061 for international callersA live webcast will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and an audio replay will be available there...

Niu Technologies to Release Fourth Quarter and Full Year 2020 Results on March 8, 2021

Written by Customer Service on February 18, 2021. Posted in Public Companies.

BEIJING, Feb. 18, 2021 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, will release its financial results for the fourth quarter and full year 2020 before the market opens on Monday, March 8, 2021.The corporate presentation and financials spreadsheets will be posted on NIU’s investor relations website at https://ir.niu.com/financial-information/quarterly-results.The Company will host an earnings conference call on Monday, March 8, 2021 at 8:00 AM U.S. Eastern Time (9:00 PM Beijing/Hong Kong Time) to discuss the financial and business results.To join via phone, participants need to register in advance of the conference call using the link provided below. Upon registration, participants will receive dial-in numbers, an event passcode, and a...

BC Craft Supply Co. Secures 45kg of High THC Flower from Canada’s First Licensed Micro Cultivator

Written by Customer Service on February 18, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE:CRFT) (FSE:ZZD1) is pleased to announce a new product into its supply chain grown by Canada’s first licensed micro cultivator, Canandia. 45kg of Death Bubba has been purchased by BC Craft and shipped to Indiva Limited (“Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) for processing into Indiva’s new premium brand, Artisan Batch. The large craft buds are processed into sleek 3.5 gram jars which are now available in BC through private and provincial retailers. Death Bubba is an indica-dominant hybrid grown in live soil and nourished with filtered water; its frosty lime green buds are caked with crystals that promise a potent punch. This limited-edition batch was meticulously developed by the experts at Canandia and their...

Verkkokauppa.com Oyj – Managers’ Transactions – Häggblom

Written by Customer Service on February 18, 2021. Posted in Public Companies.

Verkkokauppa.com Oyj MANAGERS’ TRANSACTIONS February 18, 2021 at 9:00 EETVerkkokauppa.com Oyj – Managers’ Transactions – HäggblomOn 31 March 2020, the Annual General Meeting of Verkkokauppa.com Oyj resolved that the annual fee of the company’s Board of Directors is paid in four equal instalments in Verkkokauppa.com shares either purchased from the market or alternatively by using treasury shares held by the company. In accordance with the resolution, a total of 906 shares have been transferred to Christoffer Häggblom as follows:Transaction notification under Article 19 of EU Market Abuse Regulation.Person subject to the notification requirementName: Häggblom, ChristofferPosition: Member of the Board____________________________________________Issuer: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75Notification...

Verkkokauppa.com Oyj – Johdon liiketoimet – Häggblom

Written by Customer Service on February 18, 2021. Posted in Public Companies.

Verkkokauppa.com Oyj JOHDON LIIKETOIMET 18.2.2021 klo 9.00Verkkokauppa.com Oyj – Johdon liiketoimet – HäggblomVerkkokauppa.com Oyj:n varsinainen yhtiökokous 31.3.2020 päätti, että 50 prosenttia hallituksen puheenjohtajan ja jäsenten vuosipalkkiosta maksetaan neljässä yhtä suuressa erässä markkinoilta hankittavina Verkkokauppa.comin osakkeina tai vaihtoehtoisesti käyttämällä yhtiön hallussa olevia omia osakkeita. Tämän päätöksen mukaisesti Christoffer Häggblomille on luovutettu yhteensä 906 osaketta seuraavasti: Markkinoiden väärinkäyttöasetuksen 19. artiklan mukainen ilmoitus liiketoimesta.IlmoitusvelvollinenNimi: Häggblom, ChristofferAsema: Hallituksen jäsen____________________________________________Liikkeeseenlaskija: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero:...

A strong ending of an eventful year

Written by Customer Service on February 18, 2021. Posted in Public Companies.

Press release (MAR)Malmö, February 18, 2021Acarix AB (publ) publishes Year-End Report 2020A strong ending of an eventful yearThe fourth quarter contributed strongly to our overall performance in 2020, with the market approval for CADScor® from the US Food and Drug Administration (FDA) as the outstanding achievement.Extract from CEO Per Persson’s message to the End Year Report.Fourth quarter 2020 compared with same period 2019During the fourth quarter, 22 CADScor®System (10, of which 4 to clinical trials) and 1,420 (1,500, of which 840 to clinical trials) disposable patches were sold to end-users and distributors.Revenue amounted to SEK 966 thousand (774), with gross profit of SEK 713 thousand (607) and a gross margin of 74 percent (78).Operational costs amounted to SEK 12,100 thousand (10,591).Result before tax amounted to SEK –11,411...

Month: February 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals